Muse's fast start puts it in rare company - and early data shows users stick around longer than ChatGPT or Gemini.

All-cash acquisition delivers divesiran, a late-stage-ready experimental treatment, to Merck KGaA's pipeline.

Scientists found a natural defense against protein buildup, opening a new path to preventive treatments.

Sotheby's is auctioning Copernicus, Galileo, and Newton first editions together for the first time, a rare chance to own the scientific revolution.